FDA
-
-
-
-
-
-
-
Savara Announces New Employment Inducement Grant
-
-
-
-
-
-
-
Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
-
-
-
-
-
-
-
Savara (SVRA) Reiterated at Market Outperform by Citizens Ahead of March Conference
-
-
-
-
-
-
-
Savara Announces New Employment Inducement Grant
-
-
-
-
-
-
-
Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*
-
-
-
-
-
-
-
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M
-
-
-
-
-
-
-
Savara promotes Yasmine Wasfi to chief medical officer
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

